09.12.2024.
The research team of the SVETOVID-19 project has achieved another significant result within the project “Human genetic and epigenetic determinants of susceptibility, severity and outcomes in SARS-CoV-2 infection – SVETOVID-19”.
As part of the research conducted under the SVETOVID-19 project, results have been published indicating the importance of ACE2 and TMPRSS2 gene polymorphisms as potential predictors of disease severity and outcome in women with COVID-19. The paper titled “ACE2 and TMPRSS2 genetic polymorphism as potential predictors of COVID-19 severity and outcome in females” was published in the renowned journal Frontiers in Genetics, known for the high quality of scientific work in the field of genetic research.
Matić S, Milovanović D, Vukićević V, Đurđević P, Stefanović S, Sazdanović P, Mijailović Z, Vukić M, Vuković N, Milivojević N, Jakovljević V, Filipović N, Baškić D, Đorđević N. ACE2 and TMPRSS2 genetic polymorphism as potential predictors of COVID-19 severity and outcome in females. Front Genet. 2024;15:1349592. doi:10.3389/fgene.2024.
23.-25.10.2024.
Members of the SVETOVID-19 project team participated in the International Union of Microbiological Societies Congress (IUMS 2024), held in Florence, Italy, from October 23 to 25, 2024. On that occasion, the paper titled “ACE2 and TMPRSS2 genetic polymorphism as potential predictors of COVID-19 severity and outcome in females” was presented. Through this work, the significance of genetic variations in the ACE2 and TMPRSS2 genes as potential predictors of disease severity and outcome in women with COVID-19 was highlighted.
Participation in this prestigious international event was an opportunity to present the results of the SVETOVID-19 project to the broader scientific community, as well as to establish collaboration and exchange knowledge with researchers in the fields of microbiology, virology, and genetic sciences.
25.09.2023.
The research team of the SVETOVID-19 project has made significant progress in studying the impact of genetic polymorphisms on the outcome of COVID-19 disease, within the project “Human genetic and epigenetic determinants of susceptibility, severity and outcomes in SARS-CoV-2 infection – SVETOVID-19”, funded by the Science Fund of the Republic of Serbia through the IDEAS program.
In collaboration with colleagues from the Institute for Information Technologies, University of Kragujevac, the research results indicating a potential protective role of IFN-λ4 polymorphisms in COVID-19 patients in the Serbian population have been published. The paper was published under the title "It’s all about IFN‐λ4: Protective role of IFN-λ4 polymorphism in the Serbian population with COVID‐19" in the prestigious international journal Journal of Medical Virology, which, according to KoBSON, was ranked as the second most prominent journal in the field of virology, with an impact factor of 20.693 in 2021.
Matić S, Milovanović D, Mijailović Z, Đurđević P, Sazdanović P, Todorović D, Vukićević V, Stefanović S, Vukić M, Popović S, Vuković N, Milivojević N, Živanović M, Jakovljević V, Filipović N, Baškić D, Đorđević N. It’s all about IFN‐λ4: Protective role of IFNL4 polymorphism in the Serbian population with COVID‐19. J Med Virol. 2023;95:e28811. doi:10.1002/jmv.28811.
23.02.2023.
The research team of the SVETOVID-19 project, led by prof. Dr. Dejan Baskić, achieved great success in examining the impact of genetic polymorphisms on the outcome of the COVID-19 disease, carried out within the project "Human genetic and epigenetic determinants of susceptibility, severity and outcomes in SARS-CoV-2 infection - SVETOVID-19", financed by by the Science Fund of the Republic of Serbia within the IDEJE program. In cooperation with colleagues from the Institute of Information Technologies, University of Kragujevac, the first results were published under the title "IFNL3/4 polymorphisms as a two-edged sword: An association with COVID-19 outcome" in the highly renowned virological journal Journal of Medical Virology. This journal is ranked by Cobson as the second most prominent journal in the field of virology with an impact factor of 20.693 in 2021.
Matic S, Milovanovic D, Mijailovic Z, Djurdjevic P, Sazdanovic P, Stefanovic S, Todorovic D, Popovic S, Vukicevic V, Vukic M, Vukovic N, Milivojevic N, Zivanovic M, Jakovljevic V, Filipovic N, Baskic D, Djordjevic N. IFNL3/4 polymorphisms as a two-edged sword: an association with COVID-19 outcome. J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28506. Epub ahead of print. PMID: 36655749.
